|
Volumn 10, Issue 1, 2001, Pages 39-42
|
Prevention of restenosis after percutaneous coronary interventions
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANGIOPEPTIN;
ANTICOAGULANT AGENT;
ANTILIPEMIC AGENT;
ANTIOXIDANT;
ANTITHROMBOCYTIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CARVEDILOL;
CILOSTAZOL;
CORTICOSTEROID;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
FISH OIL;
HEPARIN;
IRIDIUM 192;
PACLITAXEL;
PHOSPHODIESTERASE INHIBITOR;
PLACEBO;
PLATELET DERIVED GROWTH FACTOR;
PROBUCOL;
PROSTACYCLIN DERIVATIVE;
RAPAMYCIN;
SEROTONIN ANTAGONIST;
STRONTIUM 90;
TICLOPIDINE;
TRANILAST;
TRAPIDIL;
UNINDEXED DRUG;
VIRUS VECTOR;
YTTRIUM 90;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIOXIDANT ACTIVITY;
ARTERY DIAMETER;
ARTERY INTIMA PROLIFERATION;
ARTERY MUSCLE;
ATHERECTOMY;
BETA RADIATION;
BRACHYTHERAPY;
CELL MIGRATION;
CELL PROLIFERATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY;
CORONARY STENT;
DRUG MECHANISM;
EXCIMER LASER;
GAMMA RADIATION;
GENE TARGETING;
GENE THERAPY;
HUMAN;
LOW ENERGY RADIATION;
NONHUMAN;
RESTENOSIS;
REVIEW;
SMOOTH MUSCLE FIBER;
SURGICAL TECHNIQUE;
THROMBOCYTE FUNCTION;
TRANSLUMINAL CORONARY ANGIOPLASTY;
|
EID: 0035112671
PISSN: 10621458
EISSN: None
Source Type: Journal
DOI: 10.1016/S1062-1458(00)00195-1 Document Type: Review |
Times cited : (2)
|
References (6)
|